Role of α7-nicotinic Acetylcholine Receptor in Occurrence，Development and Therapy of Lung Cancer

Qiao LUO; Hong SHI; Shaobo WANG

doi:10.12259/j.issn.2095-610X.S20220226

Volume 43 Issue 2

Mar. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(2): 145-149

Qiao LUO, Hong SHI, Shaobo WANG. Role of α7-nicotinic Acetylcholine Receptor in Occurrence，Development and Therapy of Lung Cancer[J]. Journal of Kunming Medical University, 2022, 43(2): 145-149. doi: 10.12259/j.issn.2095-610X.S20220226

Citation:

Qiao LUO, Hong SHI, Shaobo WANG. Role of α7-nicotinic Acetylcholine Receptor in Occurrence，Development and Therapy of Lung Cancer[J]. Journal of Kunming Medical University, 2022, 43(2): 145-149. doi: 10.12259/j.issn.2095-610X.S20220226

Citation:

PDF( 544 KB)

Role of α7-nicotinic Acetylcholine Receptor in Occurrence，Development and Therapy of Lung Cancer

doi: 10.12259/j.issn.2095-610X.S20220226

Qiao LUO¹,
Hong SHI^{2
,
,},
Shaobo WANG^{1, 2
,
,}

1.
PET/CT Center，the First People Hospital of Yunnan Province，Affiliated Hospital of Kunming University of Science and Technology Kunming Yunnan 650100
2.
Institute of Primate Translational Medicine，Kunming University of Science and Technology，Kunming Yunnan 650504，China

Received Date: 2021-12-05
Available Online: 2022-02-24
Publish Date: 2022-03-04

Abstract

Abstract

Nicotinic acetylcholine receptors （nAChRs） are the central regulators of stimulatory and inhibitory neurotransmitters that control the synthesis and release of growth,angiogenic and neurotrophic factors incancer cells, the cancer microenvironment and distantmetastasis. Smoking and other possibly environmental and lifestyle factors increase the function of nAChRs that up-regulates carcinogenesis and down-regulates carcinostasis. α7-nAChRis particularly overexpressed in lung cancer cells, and participates in the proliferation, apoptosis and migration of cancer cells.Thus,α7-nAChR might be a new therapeutic target for lung cancer.
- α7-nAChR,
- Lung neoplasms,
- Molecular targeted therapy

FullText(HTML)

References(41)

References

[1]	Raso M G. N Bota-Rabassedas,Wistuba II Pathology and Classification of SCL[J]. C. Cancers (Basel),2021,13(4):820-831.
[2]	Pirker,R. Conquering lung cancer:current status and prospects for the future[J]. Pulmonology,2020,26(5):283-290. doi: 10.1016/j.pulmoe.2020.02.005
[3]	Sung H J, Ferlay R L, Siegel, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. 2021, 71（3）: 209-249.
[4]	Albuquerque E X,Pereira E F,Alkondon M,et al. Mammalian nicotinic acetylcholine receptors:from structure to function[J]. Physiol Rev,2009,89(1):73-120. doi: 10.1152/physrev.00015.2008
[5]	Malhotra J M,Malvezzi E,Negri,et al. Risk factors for lung cancer worldwide[J]. Eur Respir J,2016,48(3):889-902. doi: 10.1183/13993003.00359-2016
[6]	Hecht S S. Lung carcinogenesis by tobacco smoke[J]. Int J Cancer,2012,131(12):2724-2732. doi: 10.1002/ijc.27816
[7]	Cheng W L,Chen K Y,Lee K Y,et al. Nicotinic-nAChR signaling mediates drug resistance in lung cancer[J]. J Cancer,2020,11(5):1125-1140. doi: 10.7150/jca.36359
[8]	Kalamida,Avramopoulou D. Muscle and neuronal nicotinic acetylcholine receptors. Structure,function and pathogenicity[J]. FEBS J,2007,274(15):3799-3845. doi: 10.1111/j.1742-4658.2007.05935.x
[9]	Otvos R A,Still K B M,Somsen G W,et al. Drug Discovery on Natural Products:From Ion Channels to nAChRs,from Nature to Libraries,from Analytics to Assays[J]. SLAS Discov,2019,24(3):362-385.
[10]	Changeux J P. The nicotinic acetylcholine receptor:the founding father of the pentameric ligand-gated ion channel superfamily[J]. J Biol Chem,2012,287(48):40207-40215. doi: 10.1074/jbc.R112.407668
[11]	Rao V R,Perez-Neut M,Kaja S,et al. Voltage-gated ion channels in cancer cell proliferation[J]. Cancers (Basel),2015,7(2):849-875. doi: 10.3390/cancers7020813
[12]	Shapovalov G ,Ritaine A,Skryma R,et al. Role of TRP ion channels in cancer and tumorigenesis[J]. Semin Immunopathol,2016,38(3):357-369. doi: 10.1007/s00281-015-0525-1
[13]	Zoli M,Pistillo F,Gotti C. Diversity of native nicotinic receptor subtypes in mammalian brain[J]. Neuropharmacology,2015,96(Pt B):302-311.
[14]	Saigoh K Y,Yamagishi Y,Saito,et al. Abnormally high levels of oxidized DJ-1 in cases of Parkinson’s disease (PD) and dementia with lewy bodies (DLB)[J]. Journal of the Neurological Sciences,2017,381:774-775.
[15]	Bordas A,Cedillo J L,Arnalich F,et al. Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers[J]. J Cancer,2017,8(40):67878.
[16]	Montano-Velazquez B B,Benavides Mendez J C,Garcia-Vazquez F J,et al. Influence of Tobacco Smoke Exposure on the Protein Expression of alpha7 and alpha4 Nicotinic Acetylcholine Receptors in Squamous Cell Carcinoma Tumors of the Upper Aerodigestive Tract (Out of the Larynx)[J]. Subst Abuse,2018,12:1-5.
[17]	Moerke M J,McMahon L R,Wilkerson J L. More than Smoke and Patches:The Quest for Pharmacotherapies to Treat Tobacco Use Disorder[J]. Pharmacol Rev,2020,72(2):527-557. doi: 10.1124/pr.119.018028
[18]	Hajiasgharzadeh K, Sadigh-Eteghad S, Mansoori B, et al. Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes? [J]. J Cell Physiol, 2019, 1-14.
[19]	Al-Wadei H A,Al-Wadei M H,Masi T,et al. Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells[J]. Lung Cancer,2010,69(1):33-39. doi: 10.1016/j.lungcan.2009.09.011
[20]	Giastas P ,Zouridakis M,Tzartos S J. Understanding structure-function relationships of the human neuronal acetylcholine receptor:insights from the first crystal structures of neuronal subunits[J]. Br J Pharmacol,2018,175(11):1880-1891. doi: 10.1111/bph.13838
[21]	Whang Y M,Jo U,Sung J S,et al. Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C[J]. PLoS One,2013,8(1):e53012. doi: 10.1371/journal.pone.0053012
[22]	Dasgupta P S,Rastogi S,Pillai,et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways[J]. J Clin Invest,2006,116(8):2208-2217. doi: 10.1172/JCI28164
[23]	Tonini G, D’Onofrio L,Aquila Dell’ E,et al. New molecular insights in tobacco-induced lung cancer[J]. J Cancer,2013,9(5):649-655.
[24]	Xue J ,Yang S,Seng S. Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN[J]. Cancers (Basel),2014,6(2):1138-1156. doi: 10.3390/cancers6021138
[25]	Cattaneo M G,Codignola A,Vicentini L M,et al. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma[J]. J Cancer,1993,53(22):5566-5568.
[26]	Jull B,Plummer H,Schuller H J J,et al. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway,resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells[J]. J Cancer,2001,127(12):707-717.
[27]	Gil-Ad I,Zolokov A,Lomnitski L,et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice[J]. J Cancer,2008,33(2):277-286.
[28]	Botello J F,Corral P,Bian T,et al. Kava and its Kavalactones Inhibit Norepinephrine-induced Intracellular Calcium Influx in Lung Cancer Cells[J]. Planta Med,2020,86(1):26-31.
[29]	Grisanti L A,Talarico J A,Carter R L,et al. beta-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt[J]. J Mol Cell Cardiol,2014,72:39-51. doi: 10.1016/j.yjmcc.2014.02.009
[30]	Munoz M, Recio S, Rosso M, et al. The antiproliferative action of [D-Arg （1）, D-Phe （5）, D-Trp （7, 9）, LEU （11）] substance P analogue antagonist against smallcell-and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist, 2015, 66（3）: 421-426.
[31]	Schuller H M. Regulatory role of the alpha7nAChR in cancer[J]. Curr Drug Targets,2012,13(5):680-687. doi: 10.2174/138945012800398883
[32]	Noguchi M,Furukawa K T,Morimoto M. Pulmonary neuroendocrine cells:physiology,tissue homeostasis and disease[J]. Dis Model Mech,2020,13(12):20-37.
[33]	Shi X ,Yao J,Wang C,et al. alpha7 nicotinic acetylcholine receptor agonist attenuated the lipopolysaccharide-induced inflammatory response via inhibiting the activation of nuclear factor-KappaB][J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2017,29(4):300-305.
[34]	Tan A C. Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)[J]. Thorac Cancer,2020,11(3):511-518. doi: 10.1111/1759-7714.13328
[35]	Zhou J,Kwak K J,Wu Z,et al. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway[J]. Cell Physiol Biochem,2018,47(5):1909-1924. doi: 10.1159/000491071
[36]	Pillai S,Trevino J,Rawal B,et al. beta-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition[J]. Cancer Res,2015,75(6):1009-1020. doi: 10.1158/0008-5472.CAN-14-0681
[37]	Schuller H M. The impact of smoking and the influence of other factors on lung cancer[J]. Expert Rev Respir Med,2019,13(8):761-769. doi: 10.1080/17476348.2019.1645010
[38]	Albert-Gasco H,Ros-Bernal F,Castillo-Gomez E,et al. MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes[J]. Int J Mol Sci,2020,21(12):4471-4501.
[39]	Sun X D,Li S H,Ming Dong X Y,et al. Liquid adsorption and catalytic degradation of 4-methylnitrosamino-1-3-pyridyl-1-butanone (NNK) by zeolite[J]. Microporous and Mesoporous Materials,2017,243:39-46. doi: 10.1016/j.micromeso.2017.01.041
[40]	Improgo M R,Tapper A R,Gardner P D. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer[J]. Biochem Pharmacol,2011,82(8):1015-1021. doi: 10.1016/j.bcp.2011.05.020
[41]	Wu C H,Lee C H,Ho Y S. Nicotinic acetylcholine receptor-based blockade:applications of molecular targets for cancer therapy[J]. Clin Cancer Res,2011,17(11):3533-3541. doi: 10.1158/1078-0432.CCR-10-2434

Relative Articles(20)

Relative Articles

[1]	Ruicheng LI, Hongwei QIAN, Yanni FAN, Peipei ZHAO, Shan WEI, Huarong JING. Application of Logistic Regression and Artificial Neural Networks in the Differential Diagnosis of LC-MPE. Journal of Kunming Medical University, 2024, 45(10): 55-60. doi: 10.12259/j.issn.2095-610X.S20241009
[2]	Qun HUANG, Lili HOU, Degui WANG, Zhaojun WANG, Siyuan WU, Yingying SANG. The Effect of Active Circulatory Breathing Training in Patients undergoing Lung Cancer Surgery under 5A Mode. Journal of Kunming Medical University, 2024, 45(6): 190-196. doi: 10.12259/j.issn.2095-610X.S20240627
[3]	Qianrong YANG, Xue CAO, Jiao YANG, Yanqiu ZHAO, Nan SHEN, Ya Jiao SUN. Status and Influencing Factors of Stigma in Lung Cancer Patients. Journal of Kunming Medical University, 2024, 46(): 1-8.
[4]	Jiang ZHANG, Xijuan ZHAO, Jiang WU, Bingkun YANG, Ni YANG, Liping ZHOU. Analysis of Frailty Status and Influencing Factors in Lung Cancer Patients Undergoing Radiotherapy. Journal of Kunming Medical University, 2024, 45(9): 1-8.
[5]	Ying WANG, Cong FU, Ying FU. Clinical Implications of Serum LDH，CysC，and PWR Level Detection in Lung Cancer Patients. Journal of Kunming Medical University, 2024, 45(4): 163-169. doi: 10.12259/j.issn.2095-610X.S20240424
[6]	Hongbo ZHANG, Zhenlong LI, Ying LV, Yichao ZHANG, Xiangming QIU, Tingting HUANG. Comparison of Clinical Efficacy of Single-port and Double-port Video-assisted Thoracoscopic Lobectomy in the Treatment of Lung Cancer. Journal of Kunming Medical University, 2024, 45(4): 135-139. doi: 10.12259/j.issn.2095-610X.S20240419
[7]	Yajie SAI, Lvxin YAO, Ling CHENG, Li SHEN, Cailian QI, Zhaoxia WANG, Huatao NIU. Correlation Analysis between the Caregiver Burden and Life Meaning in Patients with the Early Diagnosis of Lung Cancer. Journal of Kunming Medical University, 2023, 44(9): 171-175. doi: 10.12259/j.issn.2095-610X.S20230906
[8]	Chenxi LI, Zhuocen ZHA, Na LI, Lin LUO, Yang YANG, Wenlin CHEN. Selection of Intensive Adjuvant Therapy for Triple-positive Breast Cancer. Journal of Kunming Medical University, 2023, 44(10): 180-188. doi: 10.12259/j.issn.2095-610X.S20231020
[9]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[10]	Chang LIU, Zhen-hua LI, Ying WANG, Yan-qin RUAN, Lai-hao QU, Ding-biao LI. Applications of Lung Cancer MDT Combined with PBL + CBL Model in the Clinical Teaching. Journal of Kunming Medical University, 2021, 42(9): 162-166. doi: 10.12259/j.issn.2095-610X.S20210911
[11]	Jiang ZHANG, Xi-juan ZHAO, Jiang WU, Yan LIU, Li-juan LI, Ye CHEN. Application of Family Empowerment Nursing Intervention Program in Patients with Lung Cancer Undergoing Radiotherapy. Journal of Kunming Medical University, 2021, 42(12): 169-176. doi: 10.12259/j.issn.2095-610X.S20211242
[12]	Ming-jie NING, Ying CHEN. Research Progress of The Correlation between Lung Microbiome and Lung Cancer. Journal of Kunming Medical University, 2021, 42(3): 155-160. doi: 10.12259/j.issn.2095-610X.S20210336
[13]	Fei SONG, Ying-ying XIANG, Ji-gui ZHANG, Jia- yin CHE, Lin LI, Ming HUANG. The Clinical Study of Bronchial Artery Infusion Chemotherapy via Radial Artery. Journal of Kunming Medical University, 2021, 42(9): 134-137. doi: 10.12259/j.issn.2095-610X.S20210921
[14]	Zhao Min , Bi Jun Qiang , Zhou Yong Chun , Zhang Jin Ping , Luo Lei . Characteristics and Trends of Disease Constitution of 9553 Inpatients with Lung Cancer in Yunnan Province. Journal of Kunming Medical University, 2017, 38(04): 63-67.
[15]	Fan Min Juan , Zhong Yun Hua , Shen Wen , Yuan Kai Fen , Zhao Guo Hou , Wang Shu Kun , Wen Lin Qiao . HSF2 Promotes Heat Shock Protein Expression in Lung Cancer. Journal of Kunming Medical University, 2017, 38(06): 108-112.
[16]	Wang Hong . Role of Prostaglandin E2 in the Pathogenesis of COPD with Lung Cancer. Journal of Kunming Medical University,
[17]	Pan Long Fang . . Journal of Kunming Medical University,
[18]	Chen Jin Run . . Journal of Kunming Medical University,
[19]	Ma Jian Qiang . . Journal of Kunming Medical University,
[20]	Chen Xian Yu . . Journal of Kunming Medical University,